Dacarbazine (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Dacarbazine drug offered from Teva Parenteral Medicines, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Dacarbazine
SUBSTANCE NAME: DACARBAZINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1998-08-27
END MARKETING DATE: 0000-00-00


Dacarbazine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDacarbazine from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/20mL)
START MARKETING DATE: 1998-08-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-5075_308fc8a0-221e-4c2f-8c88-b20ae3846f89
PRODUCT NDC: 0703-5075
APPLICATION NUMBER: ANDA075259

Other DACARBAZINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCDacarbazine
Hospira Worldwide, Inc.Dacarbazine
Teva Parenteral Medicines, Inc.Dacarbazine